Centene Corporation(CNC) Stock Research - Grey Stern Research
Loading...

Centene Corporation (CNC) Stock Analysis

$63.15 (-0.39%)

CNC Financial Performance


Use the table below to view Centene Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $63.15 -
52 Week Low $55.03 -
52 Week High $81.42 -
Market Cap $31.9 Billion 5/9
Gross Margin 10% 5/9
Profit Margin 2% 3/9
EBITDA margin 3% 4/9
Q3 - 2024 Revenue $42.0 Billion 4/9
Q3 - 2024 Earnings $713.0 Million 2/9
Q3 - 2024 Free Cash Flow -$1.1 Million 8/9
Trailing 4 Quarters Revenue $161.7 Billion 4/9
Trailing 4 Quarters Earnings $3.1 Billion 3/9
Quarterly Earnings Growth 52% 3/9
Annual Earnings Growth -16% 5/9
Quarterly Revenue Growth 10% 7/9
Annual Revenue Growth 7% 6/9
Cash On Hand $14.6 Billion 2/9
Short Term Debt $111.0 Million 6/9
Long Term Debt $17.5 Billion 4/9

Centene Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Centene Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 10.40 7/9
PS 0.20 7/9
PB 1.16 7/9
PC 2.19 8/9
Liabilities to Equity 2.01 6/9
ROA 0.04 3/9
ROE 0.11 4/9
Current Ratio 1.50 3/9
Quick Ratio 0.32 5/9
Long Term Debt to Equity 0.64 5/9
Debt to Equity 0.64 5/9
Burn Rate 1004.62 1/9
Cash to Cap 0.46 2/9
CCR -1.59 7/9
EV to EBITDA 24.76 6/9
EV to Revenue 0.22 9/9

Company Details

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

CEO: Mr. Michael Neidorff

Website: https://www.centene.com

Address: 7700 Forsyth Blvd St. Louis, MISSOURI

Exchange: New York Stock Exchange

Industry: Healthcare Plans

Centene Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Centene Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
CVS Health Corporation CVS $65.6 Billion
UnitedHealth Group Incorporated UNH $500.1 Billion
Cigna Corporation CI $79.2 Billion
Humana Inc. HUM $33.7 Billion
Molina Healthcare, Inc. MOH $16.5 Billion
Oscar Health, Inc. OSCR $3.3 Billion
Alignment Healthcare, Inc. ALHC $2.7 Billion
Bright Health Group, Inc. BHG $130.5 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
CNC Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 42.0 Billion $713.0 Million
Q2 2024 $ 39.8 Billion $1.1 Billion
Q1 2024 $ 40.4 Billion $1.2 Billion
Q4 2023 $ 39.5 Billion $45.0 Million
Q3 2023 $ 38.0 Billion $469.0 Million
Q2 2023 $ 37.6 Billion $1.1 Billion
Q1 2023 $ 38.9 Billion $1.1 Billion
Q4 2022 $ 35.6 Billion -$219.0 Million

View All

CNC Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $14.6 Billion $82.4 Billion $17.6 Billion $27.4 Billion
Q2 2024 $17.6 Billion $83.1 Billion $17.6 Billion $27.5 Billion
Q1 2024 $17.6 Billion $82.6 Billion $18.0 Billion $27.1 Billion
Q4 2023 $17.2 Billion $84.6 Billion $17.8 Billion $25.9 Billion
Q3 2023 $18.2 Billion $84.4 Billion $19.1 Billion $25.3 Billion
Q2 2023 $17.2 Billion $82.9 Billion $18.0 Billion $25.7 Billion
Q1 2023 $15.9 Billion $83.0 Billion $21.6 Billion $25.0 Billion
Q4 2022 $12.1 Billion $76.9 Billion $18.0 Billion $24.1 Billion

View All

CNC Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 -$1.1 Billion -$153.0 Million -$3.1 Billion
Q2 2024 $2.0 Billion -$186.0 Million $20.0 Million
Q1 2024 -$607.0 Million -$151.0 Million $392.0 Million
Q4 2023 -$6.0 Million -$223.0 Million -$997.0 Million
Q3 2023 $885.0 Million -$136.0 Million $922.0 Million
Q2 2023 $2.3 Billion -$215.0 Million $1.4 Billion
Q1 2023 $4.0 Billion -$225.0 Million $3.8 Billion
Q4 2022 -$1.8 Billion -$233.0 Million -$2.9 Billion

View All